Advances in the treatment of relapsed/refractory chronic lymphocytic leukemia
Crossref DOI link: https://doi.org/10.1007/s00277-017-2982-1
Published Online: 2017-04-07
Published Print: 2017-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Shustik, C.
Bence-Bruckler, I.
Delage, R.
Owen, C. J.
Toze, C. L.
Coutre, S.
Funding for this research was provided by:
Janssen Inc
License valid from 2017-04-07